Maze Therapeutics, Inc.

MAZE

MAZEMaze Therapeutics, Inc. US flag

NASDAQ

28.64

USD

-0.66

- -

1.59BMarket Cap

Income Statement (USD)

API ChatGPT

	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Sales/Revenue/Turnover	- -	- -	168	- -
+ Sales & Services Revenue	- -	- -	168	- -
- Cost of Revenue	- -	- -	- -	- -
+ Cost of Goods & Services	- -	- -	- -	- -
Gross Profit	- -	- -	- -	- -
+ Other Operating Income	- -	- -	-168	- -
- Operating Expenses	111	99	110	143
+ Selling, General & Admin	23	25	26	34
+ Research & Development	88	74	83	108
+ Other Operating Expense	- -	- -	- -	- -
Operating Income (Loss)	-111	-99	58	-143
- Non-Operating (Income) Loss	4	2	4	-12
+ Interest Expense, Net	-2	-2	-5	-12
+ Interest Expense	- -	- -	- -	- -
- Interest Income	2	2	5	12
+ Other Non-Op (Income) Loss	6	4	9	- -
Pretax Income	-115	-100	53	-131
- Income Tax Expense (Benefit)	- -	- -	1	- -
- (Income) Loss from Affiliates	- -	- -	- -	- -
Income (Loss) from Cont Ops	-115	-100	52	-131
- Net Extraordinary Losses (Gains)	- -	- -	- -	- -
+ Discontinued Operations	- -	- -	- -	- -
+ Extraord. & Accounting Changes	- -	- -	- -	- -
Income (Loss) Incl. MI	-115	-100	52	-131
- Minority Interest	- -	- -	- -	- -
Net Income, GAAP	-115	-100	52	-131
- Preferred Dividends	- -	- -	15	- -
- Other Adjustments	- -	- -	- -	- -
Net Income Avail to Common, GAAP	-115	-100	37	-131
EBIT	-111	-99	58	-143
EBITDA	-107	-94	61	-140
EBITDA Margin (%)	- -	- -	36.35	- -
EBITA	-111	-99	58	-143
Gross Margin (%)	- -	- -	100	- -
Operating Margin (%)	- -	- -	34.38	- -
Profit Margin (%)	- -	- -	31.18	- -
Sales per Employee	- -	- -	- -	- -
Dividend per Share	- -	- -	- -	- -
Depreciation Expense	4	4	3	2
Basic Weighted Avg Shares	35	35	44	43
Basic EPS, GAAP	-3.29	-2.87	0.85	-3.05
Basic EPS from Cont Ops	-3.29	-2.87	1.19	-3.05
Diluted Weighted Avg Shares	35	35	44	43
Diluted EPS, GAAP	-3.25	-2.84	0.85	-3.05
Diluted EPS from Cont Ops	-3.25	-2.84	1.19	-3.05

Balance Sheet (USD)

API ChatGPT

	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Current Assets	106	34	202	350
+ Cash, Cash Equivalents & STI	100	29	197	342
+ Cash & Cash Equivalents	100	29	197	189
+ ST Investments	- -	- -	- -	153
+ Accounts & Notes Receiv	- -	- -	- -	- -
+ Accounts Receivable, Net	- -	- -	- -	- -
+ Notes Receivable, Net	- -	- -	- -	- -
+ Loans Receivable, Net	- -	- -	- -	- -
+ Other Receivable, Net	- -	- -	- -	- -
+ Inventories	- -	- -	- -	- -
+ Raw Materials	- -	- -	- -	- -
+ Work In Process	- -	- -	- -	- -
+ Finished Goods	- -	- -	- -	- -
+ Inventory Adjustments	- -	- -	- -	- -
+ Other Inventory	- -	- -	- -	- -
+ Other ST Assets	6	5	5	8
+ Misc ST Assets	- -	- -	- -	- -
+ Prepaid Expenses	- -	- -	- -	- -
+ ST Derivative & Hedging Assets	- -	- -	- -	- -
+ ST Assets Held-for-Sale	- -	- -	- -	- -
+ ST Deferred Tax Assets	- -	- -	- -	- -
Total Noncurrent Assets	44	37	39	47
+ Property, Plant & Equip, Net	41	35	30	25
+ Property, Plant & Equip	51	49	47	44
- Accumulated Depreciation	10	14	17	19
+ LT Investments & Receivables	- -	- -	- -	18
+ LT Investments	- -	- -	- -	18
+ LT Receivables	- -	- -	- -	- -
+ Other LT Assets	3	2	9	4
+ Total Intangible Assets	- -	- -	- -	- -
+ Goodwill	- -	- -	- -	- -
+ Other Intangible Assets	- -	- -	- -	- -
+ LT Deferred Tax Assets	- -	- -	- -	- -
+ LT Derivative & Hedging Assets	- -	- -	- -	- -
+ Misc LT Assets	3	2	9	4
Total Assets	150	72	241	397
+ Payables & Accruals	9	5	8	7
+ Accounts Payable	2	2	2	2
+ Accrued Taxes	- -	- -	- -	- -
+ Interest & Dividends Payable	- -	- -	- -	- -
+ Other Payables & Accruals	7	3	6	5
+ ST Debt	4	4	5	5
+ ST Borrowings	- -	- -	- -	- -
+ ST Finance Leases	4	4	5	5
+ Other ST Liabilities	7	7	8	11
+ Deferred Revenue	- -	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -
+ Misc ST Liabilities	7	7	8	11
Total Current Liabilities	21	16	21	23
+ LT Debt	28	45	22	19
+ LT Borrowings	- -	20	- -	- -
+ LT Finance Leases	28	25	22	19
+ Other LT Liabilities	384	384	509	1
+ Accrued Liabilities	- -	- -	- -	- -
+ Pension Liabilities	- -	- -	- -	- -
+ Deferred Revenue	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -
+ Misc LT Liabilities	384	384	509	1
Total Noncurrent Liabilities	412	429	531	20
Total Liabilities	432	445	552	42
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -
+ Share Capital & APIC	13	22	47	844
+ Common Stock	- -	- -	- -	- -
+ Additional Paid in Capital	13	22	47	844
- Treasury Stock	- -	- -	- -	- -
+ Retained Earnings	-295	-396	-358	-490
+ Other Equity	- -	- -	- -	- -
Equity Before Minority Interest	-282	-374	-311	355
+ Minority/Non Controlling Interest	- -	- -	- -	- -
Total Equity	-282	-374	-311	355
Total Liabilities & Equity	150	72	241	397
Shares Outstanding	44	44	44	49
Number of Employees	- -	- -	- -	- -
Capital Leases - Total	32	30	27	23
Net Debt	-100	-9	-197	-189
Net Debt to Equity	35.37	2.43	63.25	-53.31
Tangible Common Equity Ratio	-188.36	-522.84	-129.37	89.38
Current Ratio	5.11	2.09	9.76	15.5
Cash Conversion Cycle	- -	- -	- -	- -

Cash Flow Statement (USD)

API ChatGPT

	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2022	12/31/2023	12/31/2024	12/31/2025

+ Net Income	-115	-100	52	-131
+ Depreciation & Amortization	4	4	3	2
+ Non-Cash Items	15	16	22	19
+ Stock-Based Compensation	7	9	10	16
+ Deferred Income Taxes	- -	- -	- -	- -
+ Asset Impairment Charge	2	- -	- -	- -
+ Other Non-Cash Adj	6	7	12	3
+ Chg in Non-Cash Work Cap	-3	-6	-2	-2
+ (Inc) Dec in Accts Receiv	- -	- -	- -	- -
+ (Inc) Dec in Inventories	- -	- -	- -	- -
+ (Inc) Dec in Prepaid Assets	-1	1	- -	-3
+ Inc (Dec) in Accts Payable	1	-5	4	3
+ Inc (Dec) in Other	-3	-3	-5	-3
+ Net Cash From Disc Ops	- -	- -	- -	- -
Cash from Operating Activities	-99	-87	76	-112
+ Change in Fixed & Intang	- -	- -	- -	- -
+ Disp in Fixed & Intang	- -	- -	- -	- -
+ Disp of Fixed Prod Assets	- -	- -	- -	- -
+ Disp of Intangible Assets	- -	- -	- -	- -
+ Acq of Fixed & Intang	-2	- -	-1	-1
+ Acq of Fixed Prod Assets	-2	- -	-1	-1
+ Acq of Intangible Assets	- -	- -	- -	- -
+ Cash (Repurchase) of Equity	- -	- -	- -	270
+ Increase in Capital Stock	- -	- -	- -	270
+ Decrease in Capital Stock	- -	- -	- -	- -
+ Net Change in LT Investment	- -	- -	- -	-170
+ Dec in LT Investment	- -	- -	- -	18
+ Inc in LT Investment	- -	- -	- -	-188
+ Net Cash From Acq & Div	-1	- -	- -	- -
+ Cash from Divestitures	- -	- -	- -	- -
+ Cash for Acq of Subs	-1	- -	- -	- -
+ Cash for JVs	- -	- -	- -	- -
+ Other Investing Activities	- -	- -	- -	- -
+ Net Cash From Disc Ops	- -	- -	- -	- -
Cash from Investing Activities	-3	- -	-1	-171
+ Dividends Paid	- -	- -	- -	- -
+ Net Cash From Debt	- -	16	24	- -
+ Cash From Debt	- -	16	24	- -
+ Repayments of Debt	- -	- -	- -	- -
+ Other Financing Activities	2	- -	68	5
+ Net Cash From Disc Ops	- -	- -	- -	- -
Cash from Financing Activities	2	16	93	275
Effect of Foreign Exchange Rates	- -	- -	- -	- -
Net Changes in Cash	-101	-71	168	-8
EBITDA	-107	-94	61	-140
EBITDA Margin (%)	- -	- -	36.35	- -
Free Cash Flow	-101	-87	75	-113
Net Cash Paid for Acquisitions	1	- -	- -	- -
Free Cash Flow to Firm	- -	- -	75	- -
Free Cash Flow to Equity	- -	-71	84	-113
Free Cash Flow per Basic Share	-2.89	-2.5	1.71	-2.62
Price/Free Cash Flow	- -	- -	- -	-16.02
Cash Flow to Net Income	0.86	0.86	1.45	0.85
Capital Expenditures	-2	- -	-1	-1